Experimental trial demonstrates predatory Bacteriovorax bacteria reduce pathogenic Vibrio loads and enhance survival in Pacific whiteleg shrimp, suggesting a viable biocontrol strategy for...
Vibriosis, a bacterial disease, is considered a significant threat to the sustainability and economic viability of shrimp production. The present study evaluated the application of a predatory bacterium to control the population growth of pathogenic Vibrios in Pacific whiteleg shrimp (Penaeus vannamei). The predatory bacterium was identified as Bacteriovorax sp. OP175948.1 based on the 16S rRNA sequence. The Vibrio-inhibitory activity of Bacteriovorax sp. was evaluated using two independent trials with P. vannamei, exposed to two pathogenic Vibrios, including Vibrio parahaemolyticus and Vibrio harveyi. Each trial was conducted in five treatments, including a negative control, a positive control, and a treatment with Bacteriovorax sp. applied at 102, 104, and 106 plaque-forming units mL−1 (PFU mL−1). Results indicated that shrimp infected with V. parahaemolyticus and V. harveyi, and then treated with Bacteriovorax, showed a 6-fold increase in survival for V. parahaemolyticus and a 3-fold increase for V. harveyi, relative to the control. The shrimp treated with 104 to 106 Bacteriovorax sp. improved survival associated with a significant decline in Vibrio spp. counts in the shrimp tissues and rearing water. The Bacteriovorax sp. should be used as a practical strategy to prevent Vibrio-associated mortalities in P. vannamei aquaculture.
No takes yet. Share an insight, caveat, or question.
Nievales-Naluaran et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: